INTERNATIONAL PATENT: DANA-FARBER CANCER INSTITUTE, INC. FILES APPLICATION FOR "NUCLEIC ACIDS AND ENGINEERED CELLS FOR TREATING CANCER"

GENEVA, Feb. 4 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline Ave.Boston, MA 02215-5450) filed a patent application (PCT/US2025/039355) for "NUCLEIC ACIDS AND ENGINEERED CELLS FOR TREATING CANCER" on Jul 25, 2025. With publication no. WO/2026/025087, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ROMEE, Rizwan (c/o Dana-Farber Cancer Institute, Inc.450 Brookline Ave.Boston, MA 02215-5450), TARANNUM, Mubin (c/o Dana-Farber Cancer Institute, Inc.450 Brookline Ave.Boston, MA 02215-5450), MAIA, Andreia (c/o Dana-Farber...